Erratum: The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype (Journal of Cancer Research Clinical Oncology 132, (487-497) DOI: 10.1007/s00432-006-0092-x);The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype

Journal of Cancer Research and Clinical Oncology

Volumn 132, Issue 8, 2006, Pages 487-497

  Comalada, Mònica ^a   Bailón, Elvira ^a   De Haro, Oscar ^a   Lara Villoslada, Federico ^b   Xaus, Jordi ^b   Zarzuelo, Antonio ^a   Gálvez, Julio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Puleva Biotech SA   (Spain)

Author keywords

Colonic damage; Colorectal cancer; Fermentation; Fiber; Tumor cells

Indexed keywords

BUTYRIC ACID; SHORT CHAIN FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER MODEL; CELL CULTURE; CELL PROLIFERATION; CELL REGENERATION; CELL STRAIN HT29; CELL SURVIVAL; COLITIS; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CULTURE MEDIUM; DIETARY FIBER; FEMALE; FERMENTATION; FETUS; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 33745301716     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0172-y     Document Type: Erratum

References (56)

1. Andoh A, Kinoshita K, Rosenberg I, Podolsky DK (2001) Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells. J Immunol 167:3887-3893
2. Araki Y, Andoh A, Fujiyama Y, Itoh A, Bamba T (2002) In vitro alterations in fecal short chain fatty acids and organic anions induced by the destruction of intestinal microflora under hypotonic and aerobic conditions. Int J Mol Med 9:627-631
3. Augeron C, Laboisse CL (1984) Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44:3961-3969
4. Bell CJ, Gall DG, Wallace JL (1995) Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 268:G622-G630
5. Breuer RI, Buto SK, Christ ML, Bean J, Vernia P, Paoluzi P, Di Paolo MC, Caprilli R (1991) Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci 36:185-187
6. Butzner JD, Parmar R, Bell CJ, Dalal V (1996) Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38:568-573
7. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A (1988) Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 48:1936-1942
8. Cherbut C, Michel C, Lecannu G (2003) The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133:21-27
9. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Galvez J, Zarzuelo A (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur J Immunol 35:584-592
10. D'Argenio G, Mazzacca G (1999) Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol 472:149-158
11. D'Argenio G, Cosenza V, Sorrentini I, De Ritis F, Gatto A, Delle Cave M, D'Armiento FP, Mazzacca G (1994) Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. Gastroenterology 106:399-404
12. Darzynkiewicz Z, Traganos F, Xue SB, Melamed MR (1981) Effect of n-butyrate on cell cycle progression and in situ chromatin structure of L1210 cells. Exp Cell Res 136:279-293
13. Edwards C (1994) The nutritional impact of the intestinal microflora. S Afr Med J Suppl:38S-39S
14. Waf1/Cip1 expression in normal and neoplastic tissues. Cancer Res 55:2910-2919
15. Foss FM, Veillette A, Sartor O, Rosen N, Bolen JB (1989) Alterations in the expression of pp60c-src and p561ck associated with butyrate-induced differentiation of human colon carcinoma cells. Oncogene Res 5:13-23
16. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'neil DA, Macfarlane GT (2005) Synbiotic therapy (Bifidobacterium longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54:242-249
17. Graz CJ, Cowley HM (1997) Energy state in HT-29 cells is linked to differentiation. In Vitro Cell Dev Biol Anim 33:277-281
18. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J (1997) Molecular biology of colorectal cancer. Curr Probl Cancer 21:233-300
19. Harig JM, Soergel KH, Komorowski RA, Wood CM (1989) Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 320:23-28
20. Hill MJ (1995) Bacterial fermentation of complex carbohydrate in the human colon. Eur J Cancer Prev 4:353-358
21. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA (2002) The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132:1012-1017
22. Ioachim EE, Katsanos KH, Michael MC, Tsianos EV, Agnantis NJ (2004) Immunohistochemical expression of cyclin Dl, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features. Int J Colorectal Dis 19:325-333
23. Jacobs LR (1987) Effect of dietary fiber on colonic cell proliferation and its relationship to colon carcinogenesis. Prev Med 16:566-571
24. Kagnoff MF, Eckmann L (1997) Epithelial cells as sensors for microbial infections. J Clin Invest 100:6-10
25. Kalina U, Koyama N, Hosoda T, Nuernberger H, Sato K, Hoelzer D, Herweck F, Manigold T, Singer MV, Rossol S, Bocker U (2002) Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulating of the proximal promoter region. Eur J Immunol 32:2635-2643
26. Kaur P, Potten CS (1986) Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity. Cell Tissue Kinet 19:601-610
27. Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R (2001) Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 120:71-78
28. Marchetti C, Migliorati G, Moraca R, Riccardi C, Nicoletti I, Fabiani R, Mastrandrea V, Morozzi G (1997) Deoxycholic acid and SCFA-induced apoptosis in the human tumor cell-line HT-29 and possible mechanisms. Cancer Lett 114:97-99
29. McIntyre A, Gibson PR, Young GP (1993) Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386-391
30. Medina V, Afonso JJ, Alvarez-Arguelles H, Hernandez C, Gonzalez F (1998) Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine- induced rat colon cancer. JPEN J Parenter Enteral Nutr 22:14-17
31. Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Nakayama K, Hickman JA (1995) Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 108:2261-2271
32. Merritt AJ, Allen TD, Potten CS, Hickman JA (1997) Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 14:2759-2766
33. Milovic V, Teller IC, Turchanowa L, Caspary WF, Stein J (2000) Effect of structural analogues of propionate and butyrate on colon cancer cell growth. Int J Colorectal Dis 15:264-270
34. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803
35. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 46:5-27
36. Potten CS (1995) Structure, function and proliferative organization of the mammalian gut. In: Potten CS, Hendry JH (eds) Radiation and gut. Elsevier, New York
37. Potter JD (1996) Nutrition and colorectal cancer. Cancer Causes Control 7:127-146
38. Rodriguez-Cabezas ME, Galvez J, Lorente MD, Concha A, Camuesco D, Azzouz S, Osuna A, Redondo L, Zarzuelo A (2002) Dietary fiber down-regulates colonic TNFα and nitric oxide production in the trinitrobenzenesulfonic acid-induced colitic rats. J Nutr 132:3263-3271
39. Roediger WE (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21:793-798
40. Rombeau JL, Kripke SA (1990) Metabolic and intestinal effects of short-chain fatty acids. JPEN J Parenter Enteral Nutr 14:1818-185S
41. Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E, Seidman EG (1999) Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose)polymerase (PARP). Cell Death Differ 6:729-735
42. Sanchez de Medina F, Galvez J, Romero JA, Zarzuelo A (1996) Effect of quercitrin on acute and chronic experimental colitis in the rat. J Pharmacol Exp Ther 278:771-779
43. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christi S, Richter F, Dusel G, Kasper H (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51-56
44. Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS (1992) Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 35:923-927
45. Siavoshian S, Blottiere HM, Cherbut C, Galmiche JP (1997a) Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun 232:169-172
46. Siavoshian S, Blottiere HM, Le Foll E, Kaeffer B, Cherbut C, Galmiche JP (1997b) Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro. Cell Biol Int 21:281-287
47. Souleimani A, Asselin C (1993) Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett 326:45-50
48. Tokumasa A, Katsuno T, Tanaga TS, Yokote K, Saito Y, Suzuki Y (2004) Reduction of Smad3 accelerates re-epithelialization in a murine model of colitis. Biochem Biophys Res Commun 317:377-383
49. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
50. Waseem NH, Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96:121-129
51. Weiss TS, Herfarth H, Obermeier F, Quart J, Vogl D, Scholmerich J, Jauch KW, Rogler G (2004) Intracellular polyamine levels of intestinal epithelial cells in inflammatory bowel disease. Inflamm Bowel Dis 10:529-535
52. Whitehead RH, Young GP, Bhathal PS (1986) Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM 1215). Gut 27:1457-1463
53. Whitlock JP Jr, Augustine R, Schulman H (1980) Calcium-dependent phosphorylation of histone H3 in butyrate-treated HeLa cells. Nature 287:74-76
54. Waf1. Blood 98:2124-2133
55. Young GP, McIntyre A, Albert V, Folino M, Muir JG, Gibson PR (1996) Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology 110:508-514
56. Zhang ZH, Ouyang Q, Gan HT (2004) Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells. World J Gastroenterol 10:2954-2957